Humeca

What Humeca does

Humeca, headquartered in Borne, The Netherlands, is a privately held medical device company founded in 1981 that develops, manufactures, and distributes skin grafting instruments for burn surgery. Its portfolio centers on the MEEK micrografting system—a technique re-engineered by Humeca in 1993 in cooperation with surgeons at the Red Cross Hospital Beverwijk that cuts 42mm × 42mm skin grafts into 3mm × 3mm micrografts and applies them to wound beds using pre-folded gauzes at expansion ratios of 1:2, 1:3, 1:4, 1:6, and 1:9. Supporting products include the D80 and D42 cordless battery-operated dermatomes launched in 2002 (the D42 is purpose-built for the MEEK technique and pediatric surgery, with blade speeds exceeding 7,000 strokes per minute), meshers and disposable V-carriers introduced in 2007 featuring a proprietary spring mechanism that extends blade axle life, and a line of manual knives (Humby, Humby Long, Watson, Cobbett, Silver) for free-hand graft harvesting. All products are manufactured in The Netherlands under EN ISO 13485:2016 certification.

The company generates revenue primarily from capital equipment sales and recurring consumables (disposable blades, V-carriers, and pre-folded gauzes) through three channels: its Netherlands headquarters, its wholly-owned US subsidiary Humeca Inc. in North Miami Beach, Florida, and an exclusive distribution partner network covering more than 80 countries, including Intermed for Australia/New Zealand, Marsap for India, and Ridge Biomed for Malaysia. Customers include specialized burn centers, plastic and reconstructive surgeons, and humanitarian medical organizations operating in resource-limited settings (e.g., Stichting Interplast Holland in Uganda). Go-to-market combines direct field sales, distributor relationships, conference participation at major burn care events (ANZBA, EBA, APBC), and structured MEEK surgeon certification programs.

Humeca's competitive position is anchored on its exclusive ownership of the modernized MEEK technique, more than four decades of focused specialization in burn surgery instruments since pivoting from general mechanical engineering, and an established clinical relationship network led by the Burn Center Red Cross Hospital Beverwijk and Maasstad Hospital Rotterdam. The leadership team includes CEO Arnoud van Velzen, COO Arjan van de Wolfshaar, and CCO Luis Irarragorri. In 2025 the company actively expanded its geographic footprint with new exclusive distributor partnerships in Australia and New Zealand, its first Latin American distributor meeting in Lima, Peru, and its inaugural MEEK Certification program in Latin America conducted with CENQUER.

Name

Humeca

Legal name

Humeca BV

Website

https://humeca.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

1–10 employees

Short description

Humeca is a Dutch medical device manufacturer specializing in skin grafting instruments for burn surgery, including the proprietary MEEK micrografting technique, cordless dermatomes, and meshers, sold globally through direct sales and distribution partners in over 80 countries.

Ownership category

akta.pro rank

Product category

Medical Devices for Burn Surgery / Skin Grafting Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)

akta.pro secondary industries

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Wound Care & Ulcer Management (HLAKACAN)

Keywords

• Skin grafting instruments
• Burn surgery equipment
• Micrografting systems
• Dermatome devices
• Surgical meshers

Headquarters

HQ city

Borne

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Humeca generates revenue through the sale of medical devices and instruments for skin grafting and burn surgery, including dermatomes, meshers, knives, blades, and the MEEK micrografting system. Products are sold directly through subsidiaries and through distribution partners in over 80 countries.
2. Consumables and Accessories: Recurring revenue from disposable blades, V-carriers, and prefolded gauzes used with the MEEK technique and dermatomes. Both D80 and D42 dermatomes use disposable blades to ensure sharp cutting.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Humeca designs, manufactures, and distributes medical devices for burn surgery and skin grafting procedures. Its product portfolio includes the MEEK micrografting system, cordless dermatomes, manual meshers with V-carriers, and surgical knives/blades used by burn surgeons and plastic surgeons worldwide.

Product overview

Humeca is a Dutch medical device company specializing in skin transplantation instruments for burn surgery. The product portfolio centers on the MEEK Micrografting System—a technique that cuts skin grafts into precise 3mm micrografts and expands them onto wound beds at controlled ratios. Supporting this core are two cordless dermatomes (D80 for general use, D42 for the MEEK technique), skin graft meshers with V-carriers offering multiple expansion ratios, and a range of manual knives (Humby, Humby Long, Watson, Cobbett, Silver) for free-handed graft harvesting and debridement. All products are manufactured in the Netherlands and designed to work together as an integrated toolkit covering the entire skin grafting workflow from harvest to application.

Differentiator

Problem solved

Functional benefit

Products and services

• MEEK Micrografting System

Quantifiable outcome

• Epithelialization time for 1:6 expansion using MEEK is 3-4 weeks
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• IntermedcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Intermed is Humeca's new exclusive distributor for Australia and New Zealand, announced at ANZBA 2025. This partnership represents Humeca's first participation with Intermed at the ANZBA Conference, marking a transition from the previous distributor Ozmedix.
• MarsapcoreChannel Partner/ Reseller/ DistributorMarsap is Humeca's trusted local partner in India, collaborating at the Asia Pacific Burn Conference (APBC) 2025 in Goa. Marsap represents Humeca in the Indian market for burn care products.
• Ridge BiomedcoreChannel Partner/ Reseller/ DistributorRidge Biomed is Humeca's partner representing the company in Malaysia, participating at the 5th International Burn & Wound Conference in Kuching, Malaysia alongside APAC Sales Manager Ardy Karnadi.
• CENQUERcoreStrategic or Co-development PartnerCENQUER hosted the first Meek Certification in Latin America in 2025, partnering with Humeca to advance burn care training. The certification program included 14 hours of theoretical instruction and a full week of hands-on training with 12 hours of practical work including 4 live surgeries.
• Stichting Interplast HollandminorStrategic or Co-development PartnerStichting Interplast Holland is a humanitarian organization introducing the MEEK technique in Uganda. Humeca products are used in this mission alongside doctors from Dutch burn units (Maasstad/Rotterdam and Red Cross Hospital Beverwijk). Dr Annebeth de Vries leads teaching efforts.
• Burn Center Red Cross Hospital BeverwijkcoreStrategic or Co-development PartnerHumeca developed the modified MEEK technique in cooperation with surgeons at the Burn Center Red Cross Hospital Beverwijk, The Netherlands. This partnership in the early 1990s led to the release of the modernized MEEK technique in 1993.

Scale indicators1 record

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Conmed: Medical device company offering surgical instruments and electrosurgery products, with adjacent presence in dermatomes and skin graft instrumentation for burn and plastic surgery.
• Zimmer Biomet: Large diversified medical device company with a surgical instruments portfolio including dermatomes. Broader scale and broader product portfolio than Humeca, but overlaps in skin graft harvesting instrumentation.
• Aesculap (B. Braun): B. Braun's surgical instruments division offering dermatomes and graft harvesting knives. Comparable to Humeca's manual knife line (Humby, Watson, Cobbett) and broader surgical instrument catalog.
• Integra LifeSciences: Wound care and surgical device company with regenerative tissue products and skin graft instrumentation. Adjacent competitor in burn wound management with broader portfolio.
• Smith & Nephew: Global medical device company with wound management and skin grafting products. Overlaps with Humeca in burn wound care and surgical instrumentation but operates at much larger scale.
• Organogenesis: Regenerative medicine company producing skin substitutes and wound care biologics (e.g., Apligraf). Operates in adjacent wound healing space with potential to compete with autografting techniques like MEEK.
• Stryker: Large diversified medical device company with surgical instruments portfolio relevant to burn surgery operating rooms. Comparable at the level of surgical device procurement relationships with hospitals.

Direct peers

• Exsurco Medical: Specialty manufacturer of dermatomes and skin graft products. Direct competitor to Humeca's D80/D42 dermatome product line in burn and reconstructive surgery markets.

Emerging players

• MiMedx: Regenerative medicine company specializing in placental tissue allografts for wound healing and surgical recovery. Competes indirectly with autografting for severe wound closure indications.
• Vericel Corporation: Cellular therapy company with autologous skin cell products (e.g., Epicel) for severe burns. Represents the regenerative medicine alternative to autografting techniques like Humeca's MEEK.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/humeca-inc-
• Xx.com/humecabv

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Humeca